<qa>  What is the name of the aims of the investigators?Our hypothesis is that chronic antigen exposure during peanut oral immunotherapy OIT will induce beneficial changes in the specific immune response, including: 1 anergy of IgE effector immune cells e.g., mast cells, basophils resulting in clinical desensitization; 2 induction of de novo, long lived memory B cell responses that antagonize specific IgE and confer immune tolerance. The investigators will test this hypothesis in the following specific aims: 